Charles River Laboratories International
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Charles River Laboratories International generated cash of $683,898,000, which is more than the previous year. Cash used in financing activities reached the amount of -$85,521,000 last year. Net change in cash is therefore $43,266,000.
Cash Flow
| 2014 | 251.05M | -297.99M | 61.41M |
|---|---|---|---|
| 2015 | 286.35M | -320.28M | 4.54M |
| 2016 | 298.31M | -686.37M | 390.72M |
| 2017 | 316.26M | -72.58M | -208.47M |
| 2018 | 441.14M | -955.00M | 558.05M |
| 2019 | 480.93M | -681.50M | 231.93M |
| 2020 | 546.57M | -601.54M | 47.24M |
| 2021 | 760.79M | -1.43B | 672.59M |
| 2022 | 619.64M | -607.92M | -42.39M |
| 2023 | 683.89M | -563.15M | -85.52M |
CRL Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 241.21M | 246.31M | 233.11M | 240.04M | 197.31M | 166.33M | 119.89M | 117.94M | 160.02M | 155.92M |
Operating activities | ||||||||||
Net income | 480.37M | 492.60M | 398.83M | 365.30M | 254.06M | 227.21M | 125.58M | 156.08M | 152.03M | 129.92M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 314.12M | 303.87M | 265.54M | 234.92M | 198.09M | 161.77M | 131.15M | 126.65M | 94.88M | 96.44M |
Stock-based compensation expense | 72.04M | 73.61M | 71.47M | 56.34M | 57.27M | 0 | 44.00M | 43.64M | 40.12M | 31.03M |
| Deferred income tax benefit | 72.04M | 73.61M | 71.47M | 56.34M | 57.27M | 0 | 44.00M | 43.64M | 40.12M | 31.03M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -33.43M | -150.57M | -26.63M | -85.62M | -8.32M | -21.19M | -48.27M | -52.78M | -16.96M | -28.08M |
Inventories | -62.30M | -78.52M | -25.15M | -18.37M | -21.39M | -13.33M | -17.83M | -4.02M | 3.36M | -2.95M |
Accounts payable | -20.42M | -2.65M | 44.90M | 748K | 29.77M | -12.73M | 34K | 22.07M | 1.17M | 4.59M |
Cash generated by operating activities | 683.89M | 619.64M | 760.79M | 546.57M | 480.93M | 441.14M | 316.26M | 298.31M | 286.35M | 251.05M |
Investing activities | ||||||||||
Purchases Of Investments | -54.21M | -158.27M | -45.55M | -26.69M | -22.34M | -25.12M | -46.21M | -40.24M | -34.23M | -26.64M |
Investments In Property Plant And Equipment | -318.52M | -324.73M | -228.77M | -166.56M | -140.51M | -140.05M | -82.43M | -55.28M | -63.25M | -56.92M |
Acquisitions Net | -194.78M | -120.11M | -1.17B | -418.62M | -515.70M | -824.86M | 47.45M | -648.48M | -247.65M | -234.26M |
Cash generated by investing activities | -563.15M | -607.92M | -1.43B | -601.54M | -681.50M | -955.00M | -72.58M | -686.37M | -320.28M | -297.99M |
Financing activities | ||||||||||
Common Stock Issued | 0 | 0 | 45.65M | 46.58M | 0 | 37.65M | 0 | 23.19M | 0 | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | -24.15M | -38.65M | -40.70M | -23.97M | -18.08M | -13.84M | -106.90M | -12.26M | -117.47M | -122.01M |
Repayments of term debt | -75.32M | 19.79M | -6.24B | -2.20B | 233.87M | -2.20B | -135.57M | -656.63M | 75.18M | -194.53M |
Cash used in financing activities | -85.52M | -42.39M | 672.59M | 47.24M | 231.93M | 558.05M | -208.47M | 390.72M | 4.54M | 61.41M |
Net Change In Cash | 43.26M | -5.1M | 13.19M | -6.92M | 42.72M | 30.98M | 46.43M | -321K | -42.07M | 4.09M |
Cash at end of period | 284.48M | 241.21M | 246.31M | 233.11M | 240.04M | 197.31M | 166.33M | 117.62M | 117.94M | 160.02M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |